• Filing Date: 2020-11-03
  • Form Type: 10-Q
  • Description: Quarterly report
v3.20.2
Segment Information (Summary of Operations by Segment) (Details)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
USD ($)
customer
Sep. 30, 2019
USD ($)
customer
Sep. 30, 2020
USD ($)
customer
Sep. 30, 2019
USD ($)
customer
Dec. 31, 2019
customer
Segment Reporting Information [Line Items]          
NET REVENUE $ 12,473 $ 12,850 $ 37,046 $ 36,595  
COST OF GOODS SOLD, EXCLUDING DEPRECIATION AND AMORTIZATION (1,537) (1,579) (4,949) (4,353)  
GROSS PROFIT 10,936 11,271 32,097 32,242  
RESEARCH, DEVELOPMENT AND MEDICAL AFFAIRS EXPENSES 2,469 2,761 7,162 8,322  
GENERAL AND ADMINISTRATIVE EXPENSES 2,619 3,121 8,775 10,189  
SALES AND MARKETING EXPENSES 4,764 6,437 14,818 18,458  
DEPRECIATION AND AMORTIZATION 677 668 2,016 1,974  
OPERATING EXPENSES 10,529 12,987 32,771 38,943  
NET INCOME (LOSS) FROM OPERATIONS 407 (1,716) (674) (6,701)  
OTHER INCOME AND EXPENSES, NET (1,018) (1,347) (3,633) (3,831)  
NET LOSS BEFORE TAXES (611) (3,063) (4,307) (10,532)  
United States Segment          
Segment Reporting Information [Line Items]          
NET REVENUE 6,962 8,692 17,449 22,778  
COST OF GOODS SOLD, EXCLUDING DEPRECIATION AND AMORTIZATION (746) (1,001) (1,928) (2,494)  
GROSS PROFIT 6,216 7,691 15,521 20,284  
RESEARCH, DEVELOPMENT AND MEDICAL AFFAIRS EXPENSES 1,560 1,573 4,580 4,629  
GENERAL AND ADMINISTRATIVE EXPENSES 1,952 2,032 5,867 6,116  
SALES AND MARKETING EXPENSES 3,461 4,502 10,948 12,760  
OPERATING EXPENSES 6,973 8,107 21,395 23,505  
NET INCOME (LOSS) FROM OPERATIONS $ (757) $ (416) $ (5,874) $ (3,221)  
United States Segment | Customer Concentration Risk | Sales          
Segment Reporting Information [Line Items]          
Number of customers | customer 2 2 2 2  
Concentration risk percentage 56.00% 68.00% 47.00% 62.00%  
United States Segment | Customer Concentration Risk | Accounts Receivable          
Segment Reporting Information [Line Items]          
Number of customers | customer     2   2
Concentration risk percentage     65.00%   68.00%
International Segment          
Segment Reporting Information [Line Items]          
NET REVENUE $ 5,511 $ 4,158 $ 19,597 $ 13,817  
COST OF GOODS SOLD, EXCLUDING DEPRECIATION AND AMORTIZATION (791) (578) (3,021) (1,859)  
GROSS PROFIT 4,720 3,580 16,576 11,958  
RESEARCH, DEVELOPMENT AND MEDICAL AFFAIRS EXPENSES 861 1,100 2,418 3,361  
GENERAL AND ADMINISTRATIVE EXPENSES 475 768 2,250 2,876  
SALES AND MARKETING EXPENSES 1,226 1,840 3,618 5,324  
OPERATING EXPENSES 2,562 3,708 8,286 11,561  
NET INCOME (LOSS) FROM OPERATIONS 2,158 (128) 8,290 397  
Other Segments          
Segment Reporting Information [Line Items]          
RESEARCH, DEVELOPMENT AND MEDICAL AFFAIRS EXPENSES 48 88 164 332  
GENERAL AND ADMINISTRATIVE EXPENSES 192 321 658 1,197  
SALES AND MARKETING EXPENSES 77 95 252 374  
DEPRECIATION AND AMORTIZATION 677 668 2,016 1,974  
OPERATING EXPENSES 994 1,172 3,090 3,877  
NET INCOME (LOSS) FROM OPERATIONS (994) (1,172) (3,090) (3,877)  
OTHER INCOME AND EXPENSES, NET $ (1,018) $ (1,347) $ (3,633) $ (3,831)